http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200100355-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4525
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
filingDate 1999-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2001-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-200100355-A1
titleOfInvention TREATMENT OF DEPRESSION
abstract Compound 1 '- [4- [1- (4-fluorophenyl) -1H-indol-3-yl] -1-butyl] -spiro [isobenzofuran-1 (3H), 4'-piperidine] is active on models that predict antidepressant effects, and is useful for obtaining drugs for treating depression or diseases associated with symptoms of depression. The international application was published along with an international search report.
priorityDate 1998-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679

Total number of triples: 15.